Ariadne and Cellecta to Merge Pathway Analysis and siRNA Screens for Prostate Cancer Database

The partners will use Ariadne’s software to combine siRNA screening data with information gleaned from scientific literature in order to develop a comprehensive database of prostate cancer-related information.

Full-text access for premium subscribers only. Existing premium subscribers login here.
New to GenomeWeb? Register here quickly.